Inventor · disambiguated record
Gerard R. Colca
Also filed as: COLCA GERARD R
8 granted patents·13 pending applications·53 citations·filing 2008–2024
85Inventor score
Top patents by PatentIndex Score
21 records- 0190US8067450B2Thiazolidinedione analogues for the treatment of metabolic diseasesCOLCA GERARD R·Filed 2008·Granted Nov 29, 2011·19 cites·4 claims
- 0289US8389556B2Thiazolidinedione analoguesCOLCA GERARD R·Filed 2011·Granted Mar 5, 2013·19 cites·1 claims
- 0385US8304441B2Thiazolidinedione analogues for the treatment of metabolic diseasesCOLCA GERARD R·Filed 2011·Granted Nov 6, 2012·4 cites·9 claims
- 0477US8629159B2Thiazolidinedione analoguesCOLCA GERARD R·Filed 2008·Granted Jan 14, 2014·4 cites·2 claims
- 0575US11931345B2Thiazolidinedione analogs for the treatment of NAFLD and metabolic diseasesCIRIUS THERAPEUTICS INC·Filed 2019·Granted Mar 19, 2024·1 cites·26 claims
- 0675US9155729B2Thiazolidinedione analoguesMETABOLIC SOLUTIONS DEV CO LLC·Filed 2014·Granted Oct 13, 2015·2 cites·1 claims
- 0775US9126959B2PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseasesMETABOLIC SOLUTIONS DEV CO LLC·Filed 2014·Granted Sep 8, 2015·2 cites·1 claims
- 0874US8912335B2PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseasesCOLCA GERARD R·Filed 2010·Granted Dec 16, 2014·2 cites·1 claims
- 0967US2024197689A1Thiazolidinedione analogs for the treatment of nafld and metabolic diseasesCIRIUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1062US2024216344A1Thiazolidinedione analogs for the treatment of nafld and metabolic diseasesCIRIUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1161US2009143442A1Thiazolidinedione analoguesCOLCA GERARD R·Filed 2008·Application pending·0 cites
- 1256US2023013627A1Thiazolidinedione analogs for the treatment of nafld and metabolic diseasesCIRIUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1354US2013203820A1Thiazolidinedione analoguesMETABOLIC SOLUTIONS DEV CO LLC·Filed 2013·Application pending·0 cites
- 1452US2023210825A1Methods and compositions for treating subjects with metabolic disorders and coronavirus infectionsCIRIUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1548US2016051529A1Ppar-sparing thiazolidinediones and combinations for the treatment of neurodegenerative and other metabolic diseasesMETABOLIC SOLUTIONS DEV CO LLC·Filed 2013·Application pending·0 cites
- 1647US2009143441A1Combination therapies of Thiazolidinedione analoguesCOLCA GERARD R·Filed 2008·Application pending·0 cites
- 1746US2022031667A1Thiazolidinedione analogs for the treatment of nafld and metabolic diseasesCIRIUS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1843US2012322728A1Ppar-sparing thiazolidinediones and combinations for the treatment of diabetes mellitus and other metabolic diseasesCOLCA GERARD R·Filed 2010·Application pending·0 cites
- 1936US2013281414A1Thiazolidinedione analoguesCOLCA GERARD R·Filed 2011·Application pending·0 cites
- 2036US2012316138A1Ppar-sparing thiazolidinediones and combinations for the treatment of obesity and other metabolic diseasesCOLCA GERARD R·Filed 2010·Application pending·0 cites
- 2135US2013053350A1Ppar-sparing thiazolidinediones and combinations for the treatment of neurodegenerative diseasesCOLCA GERARD R·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gerard R. Colca files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →